1 |
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia[J]. J Am Med Dir Assoc, 2014, 15 (2): 95-101.
|
2 |
Dennison EM, Sayer AA, Cooper C. Epidemiology of sarcopenia and insight into possible therapeutic targets[J]. Nat Rev Rheumatol, 2017, 13 (6): 340-347.
|
3 |
Beyer I, Mets T, Bautmans I. Chronic low-grade infla-mmation and age-related sarcopenia[J]. Curr Opin Clin Nutr Metab Care, 2012, 15 (1): 12-22.
|
4 |
Buford TW. (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease[J]. Microbiome, 2017, 5 (1): 80.
|
5 |
Yoshimura N, Muraki S, Oka H, et al. Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys[J]. Osteoporos Int, 2017, 28 (1): 189-199.
|
6 |
Kim JE, Lee YH, Huh JH, et al. Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: the fourth Korea National Health and Nutrition Examination Survey (KNHANES Ⅳ), 2008-2009[J]. Osteoporos Int, 2014, 25 (9): 2189-2198.
|
7 |
Lindsey C, Brownbill RA, Bohannon RA, et al. Asso-ciation of physical performance measures with bone mineral density in postmenopausal women[J]. Arch Phys Med Rehabil, 2005, 86 (6): 1102-1107.
|
8 |
Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity[J]. Proc Nutr Soc, 2015, 74 (4): 405-412.
|
9 |
Bindels LB, Beck R, Schakman O, et al. Restoring s-pecific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model[J]. PLoS One, 2012, 7 (6): e37971.
|
10 |
Bindels LB, Delzenne NM. Muscle wasting: the gut microbiota as a new therapeutic target?[J]. Int J Biochem Cell Biol, 2013, 45 (10): 2186-2190.
|
11 |
Collins MD, Lawson PA, Willems A, et al. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations[J]. Int J Syst Bacteriol, 1994, 44 (4): 812-826.
|
12 |
Udaondo Z, Duque E, Ramos JL. The pangenome of the genus Clostridium[J]. Environ Microbiol, 2017, 19 (7): 2588-2603.
|
13 |
Liao X, Wu R, Ma G, et al. Effects of Clostridium butyricum on antioxidant properties, meat quality and fatty acid composition of broiler birds[J]. Lipids Health Dis, 2015 (14): 36.
|
14 |
Smith GI, Julliand S, Reeds DN, et al. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults[J]. Am J Clin Nutr, 2015, 102 (1): 115-122.
|
15 |
Drachman DB, Johnston DM. Neurotrophic regulation of dynamic properties of skeletal muscle: effects of botulinum toxin and denervation[J]. J Physiol, 1975, 252 (3): 657-667.
|
16 |
Munukka E, Rintala A, Toivonen R, et al. Faecalib-acterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice[J]. ISME J, 2017, 11 (7): 1667-1679.
|
17 |
Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability[J]. Gut, 2009, 58 (8): 1091-1103.
|
18 |
Picca A, Fanelli F, Calvani R, et al. Gut dysbiosis and muscle aging: searching for novel targets against sarcopenia[J]. Mediators Inflamm, 2018: 7026198.
|
19 |
Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians[J]. PLoS One, 2010, 5 (5): e10667.
|
20 |
Ticinesi A, Lauretani F, Milani C, et al. Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?[J]. Nutrients, 2017, 9 (12): E1303.
|